Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS

Clinical trial NCT02190695 · COMPLETED

Trial details

NCT number: NCT02190695
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia

Start date: 2013-04-01
Primary completion: 2018-06-26
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.